For example, a study indicated CLK2 as an oncogenic kinase in breast cancer, and the inhibition of CLK2 led to the upregulation of genes related to epithelial‐to‐mesenchymal transition (EMT).23 The gene discussed is CLK2; the disease is breast carcinoma.